Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Seacoast Bank Welcomes Tony Coley as Regional President, South Florida
-
Prosper Gold Provides Update on Option Agreement to Acquire the Kaza and Northstar Properties
-
Infinera to Participate in J.P. Morgan’s 2024 Global Technology, Media and Communications Conference
-
APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 (florzolotau) for the Diagnosis of Progressive Supranuclear Palsy
-
Zehnder’s of Frankenmuth Announces Future Plans
-
Sow Good to Ring the Nasdaq Opening Bell Today, May 20, 2024
-
Spinogenix Announces U.S. FDA Orphan Drug Designation Granted to SPG601 for the Treatment of Fragile X Syndrome
-
NV5 Strengthens Subscription-Based Services with Acquisition of myBIMteam
-
CervoMed to Appoint William Elder as Chief Financial Officer
-
GigaGen Doses First Patient in Phase 1 Trial of Anti-CTLA-4 Oncology Drug Candidate GIGA-564 in Advanced Solid Tumors
-
Infinera Names Regan MacPherson Chief Legal Officer and Corporate Secretary
-
ABM Recognized as One of the Best Places to Work in Healthcare
-
PetMed Express, Inc. Announces Appointment of Justin Mennen to Board of Directors
-
Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Volta Medical presents results from the first transatlantic randomized controlled trial comparing AI-assisted ablation procedure with the conventional treatment for persistent atrial fibrillation pati
-
Allarity Therapeutics Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
-
Cerevance to Participate in Precision Neurotherapeutics Panel During the 2024 BIO International Convention
-
Telesign Recognized as the Best Fraud Protection Company by the Cybersecurity Excellence Awards
-
Candel Therapeutics to Host Non-Small Cell Lung Cancer (NSCLC) R&D Breakfast Panel During 2024 ASCO Annual Meeting
-
Genius Group Announces Exercise of Warrants for $3.8 Million Gross Proceeds
-
Kairous Acquisition Corp. Limited Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination
-
InnovAge Welcomes John Koehn as Senior Vice President of External Affairs
-
Scorpius Holdings Announces Major Expansion in San Antonio with New State-of-the-Art Storage and Testing Facility
-
Candel Therapeutics to Host Non-Small Cell Lung Cancer (NSCLC) R&D Breakfast Panel During 2024 ASCO Annual Meeting
-
PolarityTE Secures $22.5 Million Financing to Advance SkinTE Phase III Pivotal Study in Diabetic Foot Ulcers
-
“Breaking Points” Podcast Launches on Rumble
-
RYVYL Extends its Obligation to Repay Convertible Note to April 2026
-
Coca-Cola Consolidated Announces Commencement of Tender Offer to Purchase up to $2.0 Billion in Value of its Common Stock
-
Discover the Newest Way to Create Punchy, Flavorful Beverages
-
Soon You’ll Be Able to Measure and Improve Your Brain Performance, Anytime, Anywhere
-
Dave Cantin Group Introduces First-Ever AI-Powered Data-Mining Software to Accurately Value the Nation’s 18,000+ Franchise Dealerships
-
Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024
-
authID to Hold Annual Meeting of Stockholders on June 26th
-
Intercept Presents New Sub-Analyses of Phase 3 POISE Data Showcasing the Effect of OCA on Key Liver Biomarkers and Fibrosis in Patients with PBC at Digestive Disease Week® 2024
-
Hopebridge Continues to Grow Autism Therapy Services by Opening Two New Locations in North Carolina
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
Allarity Therapeutics Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
-
60 Degrees Pharmaceuticals Funds Babesia spp Testing in Chronic Fatigue Patient Samples in NC State College of Veterinary Medicine Study
-
Foghorn Announces Pricing of Registered Direct Offering of Common Stock and Pre-Funded Warrants
-
Alliance Trust PLC - Net Asset Value
-
Infrared Sauna Use in UCSF Clinical Trial Shows Promise in Combating Depression
-
Form 8.3 - AXA INVESTMENT MANAGERS: Darktrace plc
-
Form 8.3 - AXA INVESTMENT MANAGERS: Spirent Communications plc
-
Alta Equipment Group Announces Proposed Private Offering of $500 Million of Senior Secured Second Lien Notes
-
Leading Proxy Advisory Firms Recommend Shareholders Vote “FOR” All of Crown Castle’s Director Nominees
-
Agrify Corporation Mutually Agrees to Terminate Plan to Merge with Nature’s Miracle
-
Nexxen Reports Results for the First Quarter Ended March 31, 2024
-
Reunion Neuroscience Announces Publication of Results from Early Preclinical Studies Demonstrating the Potential of RE104 for Development in Depressive Disorders
-
BrightSpring Health Services Announces Onco360® Was Selected as National Pharmacy Partner for OJEMDA™
-
SL Green Realty Corp. Announces Common Stock Dividend
